# Sterol regulatory element-binding protein
Sterol regulatory element-binding proteins (SREBPs) are a family of membrane-bound transcription factors that control the synthesis and uptake of cholesterol, fatty acids, and triglycerides in animal cells. They belong to the basic helix-loop-helix leucine zipper (bHLH-Zip) family and are conserved from fission yeast to humans.[1](https://www.sciencedirect.com/science/article/abs/pii/S1043276011001755) Uniquely among transcription factors, SREBPs are synthesized as inactive precursors embedded in the endoplasmic reticulum (ER) membrane; the active portion is released by proteolytic cleavage only when cells need more lipid.[2](https://academic.oup.com/mend/article/27/3/384/2615014)
| Key fact | Detail |
|---|---|
| Family and class | bHLH-Zip transcription factors, membrane-bound as inactive precursors in the ER[1](https://www.sciencedirect.com/science/article/abs/pii/S1043276011001755) |
| Isoforms | Three: SREBP-1a and SREBP-1c from one gene via alternative transcription start sites, and SREBP-2 from a separate gene[3](https://pmc.ncbi.nlm.nih.gov/articles/PMC150968/) |
| Gene locations | SREBP-2 on human chromosome 22q13; SREBP-1 on 17p11.2[3](https://pmc.ncbi.nlm.nih.gov/articles/PMC150968/) |
| Activation machinery | SCAP escorts SREBP to the Golgi, where site-1 protease (S1P) and site-2 protease (S2P) release the nuclear form; Insig retains the complex in the ER when sterols are abundant[2](https://academic.oup.com/mend/article/27/3/384/2615014) |
| Target genes | The three SREBPs regulate the expression of over 30 genes[4](https://pubmed.ncbi.nlm.nih.gov/15052338/) |
| DNA binding | Bind sterol regulatory elements (SREs), typically 10 bp elements similar to the canonical LDLR sequence ATCACCCCAC, and some E-boxes[5](https://www.sciencedirect.com/topics/veterinary-science-and-veterinary-medicine/sterol-regulatory-element-binding-protein) • [6](https://www.sciencedirect.com/science/article/pii/S0163782701000108) |
| Division of labor | SREBP-1c preferentially activates fatty acid and triglyceride genes; SREBP-2 preferentially activates cholesterol genes; SREBP-1a activates both pathways[3](https://pmc.ncbi.nlm.nih.gov/articles/PMC150968/) |
## Structure and isoforms
The mammalian genome encodes two SREBP genes that produce three major proteins. SREBP-1a and SREBP-1c come from a single gene on human chromosome 17p11.2 through alternative transcription start sites that generate alternate first exons, while SREBP-2 is encoded by a gene on chromosome 22q13.[3](https://pmc.ncbi.nlm.nih.gov/articles/PMC150968/) Each precursor has an N-terminal portion containing the transcription-factor domains and a C-terminal regulatory portion, joined by membrane-spanning regions that anchor the protein in the ER.[6](https://www.sciencedirect.com/science/article/pii/S0163782701000108)
The isoforms differ in potency and specificity. SREBP-1a has a longer acidic transactivation segment in exon 1a and is a potent activator of all SREBP-responsive genes, including those for cholesterol, fatty acid, and triglyceride synthesis. SREBP-1c preferentially enhances transcription of genes required for fatty acid synthesis but not cholesterol synthesis, and SREBP-2, which also has a long activation domain, preferentially activates cholesterol synthesis.[3](https://pmc.ncbi.nlm.nih.gov/articles/PMC150968/) SREBP-1a and SREBP-2 are the predominant isoforms in most cultured cell lines, whereas SREBP-1c and SREBP-2 predominate in the liver and most intact tissues.[3](https://pmc.ncbi.nlm.nih.gov/articles/PMC150968/) SREBP-1 isoforms are abundant in liver, white adipose tissue, adrenal glands, skeletal muscle, and brain in mice and humans, while SREBP-2 is expressed ubiquitously.[7](https://pmc.ncbi.nlm.nih.gov/articles/PMC10740981/)
## Activation pathway
**The sterol switch.** Inactive SREBPs sit in the ER membrane bound to SREBP cleavage-activating protein (SCAP), an escort protein whose N-terminal half contains eight membrane-spanning helices, of which helices 2 through 6 form the sterol-sensing domain.[8](https://www.nature.com/articles/nrm1174.pdf) When cellular sterol levels are sufficient, another ER membrane protein, Insig (insulin-induced gene), binds the SCAP-SREBP complex and retains it in the ER.[2](https://academic.oup.com/mend/article/27/3/384/2615014) When sterols fall, Insig dissociates, and SCAP escorts SREBP in COPII-coated vesicles to the [Golgi apparatus](https://www.edgepedia.org/golgi-apparatus); sterols block the binding of COPII proteins to SCAP, which is the molecular basis of the feedback.[5](https://www.sciencedirect.com/topics/veterinary-science-and-veterinary-medicine/sterol-regulatory-element-binding-protein) • [9](https://www.nature.com/articles/s12276-020-0430-0.pdf)
In the Golgi, SREBP is cleaved sequentially by site-1 protease (S1P) and site-2 protease (S2P), releasing the soluble cytoplasmic N-terminal portion, which enters the nucleus and activates SRE-containing genes.[2](https://academic.oup.com/mend/article/27/3/384/2615014) SREBPs were first identified in 1993, and over the following nine years work from the Brown and Goldstein laboratory identified the five additional proteins, Scap, Insig-1, Insig-2, site-1 protease, and site-2 protease, that constitute the core pathway.[10](https://www.sciencedirect.com/topics/biochemistry-genetics-and-molecular-biology/sterol-regulatory-element-binding-protein-1a) Gene dosage studies showed that the system responds to sterol regulation only within a narrow window of Insig-1 to SCAP stoichiometry: with SCAP in molar excess, processing becomes insensitive to sterols, while a large excess of Insig-1 retains SREBP in the ER even without sterols.[11](https://www.jci.org/articles/view/21450)
**Beyond sterols.** The pathway also responds to nutrient and hormonal signals. Activation of upstream kinases such as mTORC1 can promote SCAP-mediated transport of SREBPs to the Golgi, and the switch is tuned by energy-sensing kinases, nutrient availability, and mechanical cues from the extracellular matrix.[12](https://www.nature.com/nature-index/topics/l4/regulation-of-lipid-metabolism-by-sterol-regulatory-element-binding-proteins) Insulin increases the expression of SREBP-1c, and in the liver the transition from fasting to refeeding produces a transient overshoot in lipogenesis, more than tenfold above basal, before SREBP-1c-induced Insig-1 expression restores sterol-mediated regulation.[11](https://www.jci.org/articles/view/21450)
## Target genes and metabolic programs
Activated SREBPs up-regulate enzymes of lipogenesis and sterol biosynthesis.[2](https://academic.oup.com/mend/article/27/3/384/2615014) SREBP-2-responsive genes in the cholesterol pathway include those for HMG-CoA synthase, [HMG-CoA reductase](https://www.edgepedia.org/hmg-coa-reductase), farnesyl diphosphate synthase, and squalene synthase. SREBP-1c-responsive genes include ATP citrate lyase, acetyl-CoA carboxylase, and fatty acid synthase, which together produce palmitate, as well as the elongase that converts palmitate to stearate, stearoyl-CoA desaturase, and glycerol-3-phosphate acyltransferase, the first committed enzyme of triglyceride and phospholipid synthesis. Both SREBP-1c and SREBP-2 activate three genes that generate NADPH, consumed at multiple stages of these biosynthetic pathways.[3](https://pmc.ncbi.nlm.nih.gov/articles/PMC150968/)
Regulation operates at two levels. Post-transcriptionally, sterols suppress cleavage by blocking movement of the SCAP-SREBP complex from ER to Golgi. Transcriptionally, SREBP-1c and SREBP-2 are subject to feed-forward regulation in which the nuclear forms activate their own genes through SREs in their enhancer/promoters.[3](https://pmc.ncbi.nlm.nih.gov/articles/PMC150968/) This feed-forward loop also drives expression of two closely related microRNAs, miR-33a and miR-33b, encoded within introns of the human SREBP-2 and SREBP-1 genes respectively.[13](https://pmc.ncbi.nlm.nih.gov/articles/PMC5923433/)
## Role in disease
Because SREBPs govern lipid synthesis, their deregulation is linked to several metabolic disorders, including type 2 diabetes, dyslipidemia, atherosclerosis, and hepatic steatosis.[7](https://pmc.ncbi.nlm.nih.gov/articles/PMC10740981/) In the liver, SREBPs participate in the pathogenesis of non-alcoholic fatty liver disease (NAFLD), non-alcoholic steatohepatitis (NASH), hepatitis, and hepatocellular carcinoma; altered lipid metabolism drives lipotoxicity, hepatocyte cell death, inflammation, and fibrosis that contribute to NAFLD/NASH progression and, ultimately, cancer development.[14](https://pubmed.ncbi.nlm.nih.gov/30271747/) • [7](https://pmc.ncbi.nlm.nih.gov/articles/PMC10740981/) SREBP-1 activation causes lipid-mediated cellular stress (lipotoxicity) that contributes to obesity, diabetes mellitus, dyslipidaemia, hepatosteatosis, and atherosclerosis.[15](https://www.nature.com/articles/nrendo.2017.91)
SREBPs also matter in cancer, where tumor cells must synthesize abundant membrane components and signaling molecules to support rapid growth, and several approaches, including small molecule inhibitors and [RNA interference](https://www.edgepedia.org/rna-interference), have been explored to inhibit SREBP activation or function.[16](https://www.spandidos-publications.com/10.3892/or.2026.9149/download) Several SREBP inhibitors have potential for treating obesity, diabetes, and cancer.[14](https://pubmed.ncbi.nlm.nih.gov/30271747/) Beyond pathology, SREBPs regulate physiological functions of organs including the thyroid, brain, heart, pancreas, and hormone synthesis.[14](https://pubmed.ncbi.nlm.nih.gov/30271747/)
## Comparative biology
The SREBP pathway is conserved across eukaryotes, and comparative analysis of SREBP and HMG-CoA reductase regulation in mammals, yeast, and flies points toward an equilibrium model in which lipid signals regulate the activity of sterol-sensing proteins and their downstream effectors.[17](https://www.annualreviews.org/doi/10.1146/annurev.genet.41.110306.130315) In mammalian cells, Insig additionally controls the sterol-dependent degradation of HMG-CoA reductase itself, making it a key component of homeostatic regulation on two fronts.[17](https://www.annualreviews.org/doi/10.1146/annurev.genet.41.110306.130315)
## References
1. [SREBPs: metabolic integrators in physiology and metabolism, ScienceDirect (Current Opinion in Clinical Nutrition & Metabolic Care)](https://www.sciencedirect.com/science/article/abs/pii/S1043276011001755)
2. [Mandl J, Mészáros T, Bánhegyi G, Csala M. Minireview: Endoplasmic Reticulum Stress: Control in Protein, Lipid, and Signal Homeostasis. Molecular Endocrinology 27(3):384-393 (2013)](https://academic.oup.com/mend/article/27/3/384/2615014)
3. [Horton JD, Goldstein JL, Brown MS. SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. J Clin Invest 109:1125-1131 (2002)](https://pmc.ncbi.nlm.nih.gov/articles/PMC150968/)
4. [McPherson R, Gauthier A. Molecular regulation of SREBP function: the Insig-SCAP connection and isoform-specific modulation of lipid synthesis. Biochem Cell Biol 82:201-211 (2004)](https://pubmed.ncbi.nlm.nih.gov/15052338/)
5. [Sterol Regulatory Element-Binding Protein - an overview, ScienceDirect Topics](https://www.sciencedirect.com/topics/veterinary-science-and-veterinary-medicine/sterol-regulatory-element-binding-protein)
6. [Sakai J et al. Sterol regulatory element-binding proteins (SREBPs): transcriptional regulators of lipid synthetic genes. Progress in Lipid Research 40:439-452 (2001)](https://www.sciencedirect.com/science/article/pii/S0163782701000108)
7. [SREBP Regulation of Lipid Metabolism in Liver Disease, and Therapeutic Strategies. Biomolecules 11:3280 (2021)](https://pmc.ncbi.nlm.nih.gov/articles/PMC10740981/)
8. [Rawson RB. The SREBP pathway - insights from insigs and insects. Nature Reviews Molecular Cell Biology 4:631-640 (2003)](https://www.nature.com/articles/nrm1174.pdf)
9. [The cellular function of SCAP in metabolic signaling. Experimental & Molecular Medicine (2020)](https://www.nature.com/articles/s12276-020-0430-0.pdf)
10. [Sterol Regulatory Element Binding Protein 1a - an overview, ScienceDirect Topics](https://www.sciencedirect.com/topics/biochemistry-genetics-and-molecular-biology/sterol-regulatory-element-binding-protein-1a)
11. [Attie AD. Insig: a significant integrator of nutrient and hormonal signals. J Clin Invest 113:1112-1114 (2004)](https://www.jci.org/articles/view/21450)
12. [Regulation of Lipid Metabolism by Sterol Regulatory Element-Binding Proteins, Nature Index summary](https://www.nature.com/nature-index/topics/l4/regulation-of-lipid-metabolism-by-sterol-regulatory-element-binding-proteins)
13. [SREBPs in Lipid Metabolism, Insulin Signaling, and Beyond. Trends in Endocrinology & Metabolism (2018)](https://pmc.ncbi.nlm.nih.gov/articles/PMC5923433/)
14. [Role of SREBPs in Liver Diseases: A Mini-review. J Clin Transl Hepatol (2018)](https://pubmed.ncbi.nlm.nih.gov/30271747/)
15. [Shimano H, Sato R. SREBP-regulated lipid metabolism: convergent physiology - divergent pathophysiology. Nature Reviews Endocrinology 13:710-730 (2017)](https://www.nature.com/articles/nrendo.2017.91)
16. [Sterol regulatory element-binding proteins: Master regulators of lipid metabolic reprogramming in cancer and emerging therapeutic targets. Oncology Reports (2026)](https://www.spandidos-publications.com/10.3892/or.2026.9149/download)
17. [Espenshade PJ, Hughes AL. Regulation of Sterol Synthesis in Eukaryotes. Annual Review of Genetics 41:401-427 (2007)](https://www.annualreviews.org/doi/10.1146/annurev.genet.41.110306.130315)
---
*Topic: Encyclopedia › Life and health › Biological foundations › Biochemistry and metabolism › Metabolism and metabolic pathways › Lipid and fatty acid metabolism › Cholesterol and steroid metabolism › Sterol regulatory responses (SREBP and cholesterol homeostasis sensing)*
*Initially written Sep 17, 2026 · Reviewed: Oct 21, 2026 · Edited: Oct 15, 2026; Oct 21, 2026 · Last review: Oct 21, 2026*
*Copyright 2026 EdgeChat AI, a subsidiary of Biostate AI.*
License: Edgepedia Community License 1.0, https://www.edgepedia.org/edgepedia/license